FDA Aims For Greater Role In Pharma Business Continuity Planning

20 Mar 2019

Legislative proposals described in the US FDA’s FY 2020 budget request justification document would give the agency more authority to oversee business continuity planning at pharmaceutical companies with the idea of preventing shortages of essential drugs.

business continuity plan management strategy assesment bcp

The US FDA would become more involved in pharmaceutical manufacturing business continuity planning under several legislative proposals outlined in the agency’s fiscal year 2020 budget request.

One proposal would give FDA more authority to make application holders for “certain drugs” periodically assess the risk of supply...